Expert NetworkExpert InterviewKPTI

Slingshot members are talking to an expert! The topic is:

A look at the new data from the Phase 2 XPORT-MF-035 trial evaluating Karyopharm's selinexor in a heavily pretreated myelofibrosis population.

Executed on:Jun 3, 2025 12:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Vanderbilt University Medical Center
  • Assistant Professor of Medicine, Hematology/Oncology at Vanderbilt University Medical Center
  • Manages 60 patients with Myelofibrosis and 10+ with CML
  • Completed fellowship in experimental therapeutics from Taussig Cancer institute in 2021 and research focuses on cancer biology

Interview Goal

On this call we will be discussing he current treatment landscape for myelofibrosis and your thoughts on new data from the Phase 2 XPORT-MF-035 trial evaluating selinexor monotherapy in a heavily pretreated myelofibrosis population.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.